These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 30817164)
1. Selective Cytotoxicity to HER2 Positive Breast Cancer Cells by Saporin-Loaded Nanobody-Targeted Polymeric Nanoparticles in Combination with Photochemical Internalization. Martínez-Jothar L; Beztsinna N; van Nostrum CF; Hennink WE; Oliveira S Mol Pharm; 2019 Apr; 16(4):1633-1647. PubMed ID: 30817164 [TBL] [Abstract][Full Text] [Related]
2. Photochemical internalization (PCI) of HER2-targeted toxins: synergy is dependent on the treatment sequence. Berstad MB; Weyergang A; Berg K Biochim Biophys Acta; 2012 Dec; 1820(12):1849-58. PubMed ID: 22981913 [TBL] [Abstract][Full Text] [Related]
3. Light-controlled endosomal escape of the novel CD133-targeting immunotoxin AC133-saporin by photochemical internalization - A minimally invasive cancer stem cell-targeting strategy. Bostad M; Olsen CE; Peng Q; Berg K; Høgset A; Selbo PK J Control Release; 2015 May; 206():37-48. PubMed ID: 25758331 [TBL] [Abstract][Full Text] [Related]
4. Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles. Colzani B; Pandolfi L; Hoti A; Iovene PA; Natalello A; Avvakumova S; Colombo M; Prosperi D Int J Nanomedicine; 2018; 13():957-973. PubMed ID: 29491709 [TBL] [Abstract][Full Text] [Related]
5. EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy. Liu Y; Scrivano L; Peterson JD; Fens MHAM; Hernández IB; Mesquita B; Toraño JS; Hennink WE; van Nostrum CF; Oliveira S Mol Pharm; 2020 Apr; 17(4):1276-1292. PubMed ID: 32142290 [No Abstract] [Full Text] [Related]
6. Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice. Xenaki KT; Dorrestijn B; Muns JA; Adamzek K; Doulkeridou S; Houthoff H; Oliveira S; van Bergen En Henegouwen PM Theranostics; 2021; 11(11):5525-5538. PubMed ID: 33859761 [No Abstract] [Full Text] [Related]
7. Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells. Abou-El-Naga AM; Mutawa G; El-Sherbiny IM; Mousa SA Int J Nanomedicine; 2018; 13():8153-8164. PubMed ID: 30555232 [TBL] [Abstract][Full Text] [Related]
8. Multifunctional HER2-antibody conjugated polymeric nanocarrier-based drug delivery system for multi-drug-resistant breast cancer therapy. Vivek R; Thangam R; NipunBabu V; Rejeeth C; Sivasubramanian S; Gunasekaran P; Muthuchelian K; Kannan S ACS Appl Mater Interfaces; 2014 May; 6(9):6469-80. PubMed ID: 24780315 [TBL] [Abstract][Full Text] [Related]
9. Dual-Targeted Delivery of Nanoparticles Encapsulating Paclitaxel and Everolimus: a Novel Strategy to Overcome Breast Cancer Receptor Heterogeneity. Houdaihed L; Evans JC; Allen C Pharm Res; 2020 Jan; 37(3):39. PubMed ID: 31965330 [TBL] [Abstract][Full Text] [Related]
10. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid). Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340 [TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy. Chen H; Gao J; Lu Y; Kou G; Zhang H; Fan L; Sun Z; Guo Y; Zhong Y J Control Release; 2008 Jun; 128(3):209-16. PubMed ID: 18450313 [TBL] [Abstract][Full Text] [Related]
12. 5-FU resistant EMT-like pancreatic cancer cells are hypersensitive to photochemical internalization of the novel endoglin-targeting immunotoxin CD105-saporin. Lund K; Olsen CE; Wong JJW; Olsen PA; Solberg NT; Høgset A; Krauss S; Selbo PK J Exp Clin Cancer Res; 2017 Dec; 36(1):187. PubMed ID: 29258566 [TBL] [Abstract][Full Text] [Related]
13. The novel EpCAM-targeting monoclonal antibody 3-17I linked to saporin is highly cytotoxic after photochemical internalization in breast, pancreas and colon cancer cell lines. Lund K; Bostad M; Skarpen E; Braunagel M; Kiprijanov S; Krauss S; Duncan A; Høgset A; Selbo PK MAbs; 2014; 6(4):1038-50. PubMed ID: 24525727 [TBL] [Abstract][Full Text] [Related]
14. Docetaxel immunonanocarriers as targeted delivery systems for HER 2-positive tumor cells: preparation, characterization, and cytotoxicity studies. Koopaei MN; Dinarvand R; Amini M; Rabbani H; Emami S; Ostad SN; Atyabi F Int J Nanomedicine; 2011; 6():1903-12. PubMed ID: 21931485 [TBL] [Abstract][Full Text] [Related]
15. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Sun B; Ranganathan B; Feng SS Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985 [TBL] [Abstract][Full Text] [Related]
16. Enhanced cytotoxicity of saporin by polyamidoamine dendrimer conjugation and photochemical internalization. Lai PS; Pai CL; Peng CL; Shieh MJ; Berg K; Lou PJ J Biomed Mater Res A; 2008 Oct; 87(1):147-55. PubMed ID: 18085655 [TBL] [Abstract][Full Text] [Related]
17. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells. Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438 [TBL] [Abstract][Full Text] [Related]
18. Cisplatin-loaded PLGA nanoparticles for HER2 targeted ovarian cancer therapy. Domínguez-Ríos R; Sánchez-Ramírez DR; Ruiz-Saray K; Oceguera-Basurto PE; Almada M; Juárez J; Zepeda-Moreno A; Del Toro-Arreola A; Topete A; Daneri-Navarro A Colloids Surf B Biointerfaces; 2019 Jun; 178():199-207. PubMed ID: 30856589 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line. Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678 [TBL] [Abstract][Full Text] [Related]